The global demand for Artificial Tears Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
An artificial tear is a medication used to treat dry, irritated eyes caused due to wind, sun, heating or air conditioning, computer use or reading, and certain medications. This solution acts as a lubricant or moisturizer that promotes healing of the eyes, and work to decrease tear evaporation. It functions by supplementing a patient's produced tears and increase eye lubrication by mimicking characteristics of the tear film, and provides temporary relief from burning and discomfort due to dryness of the eye.
Market Dynamics
Rising cases of dry eye syndrome (DES) and eye-related problems worldwide, a growing elderly population that is more prone to this condition, and technological advances are stimulating demand for artificial tears. Dry eye disease is a major global health problem with symptoms such as burning, photophobia, tearing, and grittiness. Dry eye syndrome prevalence increases with the rise in air pollution, excessive use of digital gadgets, lack of nutrition, chronic conjunctivitis, poor eyelid, scars of eye injury. Artificial tears medication demand is also projected to swell with an increasing number of people wearing contact lens. However, the dry eye problem is poorly understood in some parts of the world, restraining market growth. Moreover, the excessive usage of artificial tears often leads to side effects, limiting its use.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial tears. The growth and trends of artificial tears industry provide a holistic approach to this study.
Market Segmentation
This section of the artificial tears market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Category
- Eye Drops With Preservatives
- Preservative-free Eye Drops
By Product Type
- Cellulose-derived Tears
- Glycerin-derived Tears
- Oil-based Emulsion Tears
- Polyethylene Glycol
- Propylene Glycol-based Tears
By Delivery Method
By Application
- Dry Eyes Treatment
- Contact Lenses Moisture
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Artificial Tears market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Artificial Tears Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial tears market include Allegan Inc., Alcon Inc., Santen Pharmaceuticals Novartis International AG, Bausch & Lomb, McNEIL-PPC, Inc., Advanced Vision Research, Inc., and Abbott Medical Optics Inc.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.